CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision ...
OXFORD, England & VIENNA, Austria--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the initiation of EXCYTE-1, a prospective observational study in ovarian cancer to investigate the ...
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing This prospective, interventional cohort ...
The ABRAT™-H study was conducted in Omaha, Nebraska, USA, from November 2024 to August 2025, focusing on hospitalized patients, whereas the ABRAT™-ED study was conducted among patients who visited two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results